Doceree Introduces Real-Time Clinical Intent Signals for Healthcare Marketing
Event summary
- Doceree launched Clinical Intent Signals (CIS), the first real-time clinical intent layer for omnichannel healthcare marketing.
- Pilot data showed 38% faster HCP stage progression, 27% higher contextual engagement, and 21% media efficiency gains.
- CIS will be available via the Daily Command Marketplace starting July 14, 2026.
- Doceree claims CIS enables intent-based marketing, shifting from static segmentation and retrospective analytics.
The big picture
Doceree's Clinical Intent Signals represent a significant shift in healthcare marketing, moving from retrospective data analysis to real-time clinical intent detection. This aligns with broader industry trends toward personalized, data-driven marketing strategies. The success of CIS could redefine how life science companies engage with healthcare professionals, potentially setting a new standard for omnichannel marketing in the sector.
What we're watching
- Adoption Pace
- How quickly life science marketers will integrate CIS into their omnichannel strategies.
- Competitive Response
- Whether existing healthcare marketing platforms will develop similar real-time intent capabilities.
- Regulatory Compliance
- The extent to which CIS can maintain PHI compliance and MLR governance while scaling.
Related topics